Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Luiza Kusz"'
Autor:
Jacek Roliński, Anna Dmoszyńska, Sylwia Chocholska, Agata Surdacka, Maria Luiza Kusz, Ewa Wąsik-Szczepanek, Iwona Hus, Małgorzata Sieklucka, Agnieszka Bojarska-Junak
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 49, Iss 1, Pp 98-103 (2011)
Par-4 (prostate apoptosis response-4) protein was originally found upregulated in prostate tumor cells undergoing apoptosis. Then it was further identified as a proapoptotic protein upregulated both in normal and leukemic lymphocytes. The aim of our
Externí odkaz:
https://doaj.org/article/967cba0ba7f24fa3954a00b88375eda3
Autor:
Agata Surdacka, Agnieszka Bojarska-Junak, Anna Dmoszynska, Iwona Hus, Maria Luiza Kusz, Sylwia Chocholska, Malgorzata Sieklucka, Ewa Wąsik-Szczepanek, Jacek Roliński
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 49, Iss 1, Pp 98-103 (2011)
Par-4 (prostate apoptosis response-4) protein was originally found upregulated in prostate tumor cells undergoing apoptosis. Then it was further identified as a proapoptotic protein upregulated both in normal and leukemic lymphocytes. The aim of our
Autor:
Anna Dmoszynska, Iwona Hus, Paulina Wdowiak, Jacek Roliński, Monika Legieć, Magdalena Lewandowska, Jacek Tabarkiewicz, Magdalena Wasiak, Maria Luiza Kusz
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 49, Iss 1, Pp 153-160 (2011)
Immunotherapy with dendritic cells (DC) may constitute a new and advantageous option for patients with chronic myeloid leukemia (CML) who respond to therapy with tyrosine kinase inhibitors (TKI), but do not reach complete cytogenetic or molecular rem
Autor:
Agnieszka Bojarska-Junak, Aneta Dobrzyńska-Rutkowska, Anna Dmoszynska, Elżbieta Starosławska, Anna Twardosz, Jacek Roliński, Magdalena Wasiak, Iwona Hus, Agata Surdacka, Paulina Wdowiak, Maria Luiza Kusz
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 49, Iss 1, Pp 183-187 (2011)
Diffuse large B-cell lymphoma is the commonest histological type of malignant lymphoma, and remains incurable in many cases. Developing more efficient immunotherapy strategies will require better understanding of the disorders of immune responses in